BUMBLE Trademark

Trademark Overview


On Thursday, December 19, 2019, a trademark application was filed for BUMBLE with the United States Patent and Trademark Office. The USPTO has given the BUMBLE trademark a serial number of 88733330. The federal status of this trademark filing is SUSPENSION INQUIRY - MAILED as of Friday, January 3, 2025. This trademark is owned by Bumble Holding Limited. The BUMBLE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, antibacterial pharmaceuticals, ocular pharmaceuticals, pharmaceuticals for the treatment of viral infections, pharmaceuticals for the treatment of viral diseases, therapeutic pharmaceuticals for the treatment of sexually transmitted infections, pharmaceuticals for the treatment of hormonal disorders, injectable contraceptives, inducers of erections, effervescent analgesic pharmaceutical preparations, bismuth preparations for pharmaceutical purposes, anti-infectives, royal jelly for pharmaceutical purposes, pharmaceutical preparations for treating sunburn, pharmaceutical preparations for skin care, balms for pharmaceutical purposes, pharmaceutical skin lotions, anti-diabetic pharmaceuticals, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for treating chemical imbalances, pharmaceutical agents affecting sensory organs, pharmaceutical agents affecting metabolism, analgesic and muscle relaxant pharmaceutical preparat...
bumble

General Information


Serial Number88733330
Word MarkBUMBLE
Filing DateThursday, December 19, 2019
Status651 - SUSPENSION INQUIRY - MAILED
Status DateFriday, January 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals, namely, antibacterial pharmaceuticals, ocular pharmaceuticals, pharmaceuticals for the treatment of viral infections, pharmaceuticals for the treatment of viral diseases, therapeutic pharmaceuticals for the treatment of sexually transmitted infections, pharmaceuticals for the treatment of hormonal disorders, injectable contraceptives, inducers of erections, effervescent analgesic pharmaceutical preparations, bismuth preparations for pharmaceutical purposes, anti-infectives, royal jelly for pharmaceutical purposes, pharmaceutical preparations for treating sunburn, pharmaceutical preparations for skin care, balms for pharmaceutical purposes, pharmaceutical skin lotions, anti-diabetic pharmaceuticals, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for treating chemical imbalances, pharmaceutical agents affecting sensory organs, pharmaceutical agents affecting metabolism, analgesic and muscle relaxant pharmaceutical preparations, pharmaceutical preparations for treating dandruff; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; medical preparations, namely, diagnostic preparations for medical purposes; medical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; veterinary preparations, namely, antioxidants and diagnostic preparations for veterinary purposes; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food adapted for medical use; dietetic substances, namely, dietetic preparations adapted for medical purposes; dietetic foods adapted for veterinary use; dietary supplements for humans and animals; medical plasters; material for dressings, namely, wading for dressings; medicated lotions and creams, namely, anti-fly lotion, calamine lotions, sports cream for relief of pain, orgasm creams, topical analgesic creams, anti-itch creams, antibiotic creams, and medicated creams for dermatological use; medicated lotions and creams, namely, medicated hair lotions, medicated after-shave lotions, medical creams for skin care, medicated cream soap, and medicated lotions and creams for the care of sunburn; medicated skin care preparations, namely, antiseptic creams; medicated skin care preparations, namely, nappy-rash creams; dietary supplements consisting of vitamins; dietetic preparations adapted for medical purposes; dietary and nutritionally fortified food products adapted for medical use, namely, dietary supplements; vitamins and dietary supplements; dietary supplemental drinks in the nature of mineral beverages; dietary supplemental drinks in the nature of vitamin beverages; vitamin preparations in the nature of food supplements; dietary supplement drinks; flaxseed dietary supplements; linseed dietary supplements; protein dietary supplements; pea protein dietary supplements; lecithin dietary supplements; sunflower lecithin dietary supplements; preparations of vitamins; food supplements; health food supplements; herbal supplements for boosting energy; royal jelly dietary supplements; therapeutic and dietary products and preparations containing pollen, namely, processed bee pollen for medicinal or therapeutic purposes; herbal honey throat lozenges; vitamin and mineral supplements; vitamin and mineral supplements containing pollen and honey; rubbing compounds and anti-inflammatory gels containing pollen and honey for medical purposes; material for stopping teeth; dental wax; disinfectants; fungicides; herbicides; personal sexual lubricants; sexual stimulant gels; sanitary sterilizing preparations; hand sanitizers; sanitary preparations for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBumble Holding Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLONDON E16RS
GB

Trademark Events


Event DateEvent Description
Monday, December 23, 2019NEW APPLICATION ENTERED
Friday, December 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 14, 2020ASSIGNED TO EXAMINER
Sunday, February 23, 2020NON-FINAL ACTION WRITTEN
Sunday, February 23, 2020NON-FINAL ACTION E-MAILED
Sunday, February 23, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 3, 2020ASSIGNED TO LIE
Tuesday, September 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 15, 2020SUSPENSION LETTER WRITTEN
Thursday, October 15, 2020LETTER OF SUSPENSION E-MAILED
Thursday, October 15, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 23, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, October 29, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, November 7, 2021SUSPENSION INQUIRY WRITTEN
Sunday, November 7, 2021INQUIRY TO SUSPENSION E-MAILED
Sunday, November 7, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, May 5, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, May 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 5, 2022SUSPENSION LETTER WRITTEN
Tuesday, July 5, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, July 5, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 9, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, March 13, 2023SUSPENSION INQUIRY WRITTEN
Monday, March 13, 2023INQUIRY TO SUSPENSION E-MAILED
Monday, March 13, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, May 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 19, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, January 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 16, 2024SUSPENSION LETTER WRITTEN
Tuesday, January 16, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, January 16, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 25, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 25, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 3, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, January 3, 2025INQUIRY TO SUSPENSION E-MAILED
Friday, January 3, 2025SUSPENSION INQUIRY WRITTEN
Tuesday, April 1, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, April 1, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, July 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 2, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, December 18, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, July 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE